Granulysin in human serum as a marker of cell‐mediated immunity

Granulysin is a cytolytic granule protein of natural killer (NK) cells and cytotoxic T lymphocytes (CTL) with a broad range of antimicrobial and tumoricidal activities. Two molecular forms of granulysin, the 15‐kDa precursor and 9‐kDa mature form, are produced in these cells. In this study, we developed monoclonal antibodies against granulysin and found that the 15‐kDa granulysin is spontaneously secreted by peripheral blood NK and T cells via a non‐granule exocytotic pathway. When NK cells killed the target cells, the released granulysin levels in culture supernatants significantly increased through the granule exocytosis. The granulysin protein was found in the sera of healthy individuals at an average concentration of 3.7±3.2 ng/ml (age 0–99 years, n=244). The serum levels of granulysin were transiently highly elevated among patients with acute viral infections. In addition, the serum granulysin levels in patients with severe immunodeficiency treated bycell therapy fluctuated proportionately to the improvement of other immunological parameters. Our results suggest that granulysin is well associated with diverse activities of NK cells and CTL in physiological and pathological settings and could be a useful novel serum marker to evaluate the overall status of host cellular immunity.

[1]  R. Zinkernagel,et al.  The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses , 1995, European journal of immunology.

[2]  J. Trapani,et al.  Unlocking the secrets of cytotoxic granule proteins , 2001, Journal of leukocyte biology.

[3]  K. Baetz,et al.  Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re‐filling of the lytic granules and secretion of lytic proteins via a non‐granule pathway , 1995, European journal of immunology.

[4]  T. Tsurumi,et al.  Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. , 1999, Journal of immunology.

[5]  M. Brown,et al.  Soluble CD8 during T cell activation. , 1989, Journal of immunology.

[6]  S. Mcnerlan,et al.  Changes in Natural Killer Cells, the CD57CD8 Subset, and Related Cytokines in Healthy Aging , 2004, Journal of Clinical Immunology.

[7]  J. Bell,et al.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.

[8]  A. Krensky,et al.  Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. , 1997, Journal of immunology.

[9]  Kraan,et al.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) , 1999, Clinical and experimental immunology.

[10]  A. Krensky,et al.  T-cell release of granulysin contributes to host defense in leprosy , 2001, Nature Medicine.

[11]  T. Ganz,et al.  Granulysin, a T Cell Product, Kills Bacteria by Altering Membrane Permeability1 , 2000, The Journal of Immunology.

[12]  T. van der Poll,et al.  Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria. , 2000, The Journal of infectious diseases.

[13]  K. Matsushima,et al.  Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. , 2002, International immunology.

[14]  P. Lipsky,et al.  Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. , 1999, The Journal of clinical investigation.

[15]  J. Alexander,et al.  Flow cytometric analysis of lymphocyte subset phenotypes comparing normal children and adults. , 1987, Diagnostic and clinical immunology.

[16]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.

[17]  C. Hack,et al.  Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. , 1999, The Journal of infectious diseases.

[18]  P. Soccal,et al.  Quantification of cytotoxic T-cell gene transcripts in human lung transplantation. , 2000, Transplantation.

[19]  M. Simon,et al.  Perforin Is Essential for Control of Ectromelia Virus but Not Related Poxviruses in Mice , 1999, Journal of Virology.

[20]  E. Raz,et al.  Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Kishida,et al.  Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer , 2001, Cancer Immunology, Immunotherapy.

[22]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[23]  R. Zinkernagel,et al.  Perforin dependence of natural killer cell‐mediated tumor control in vivo , 1995, European journal of immunology.

[24]  G. Ogg,et al.  Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.

[25]  T. Strom,et al.  Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. , 2001, Transplantation.

[26]  O. Martinez,et al.  Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. , 1995, Transplant immunology.

[27]  R. Krishnaraj,et al.  Preferential accumulation of mature NK cells during human immunosenescence , 1992, Journal of cellular biochemistry.

[28]  A. Krensky,et al.  Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. , 2001, Viral immunology.

[29]  M. Sarwal,et al.  Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. , 2001, Human immunology.

[30]  A. Krensky,et al.  Biosynthesis of granulysin, a novel cytolytic molecule. , 1999, Molecular immunology.

[31]  A. Krensky,et al.  Bactericidal and Tumoricidal Activities of Synthetic Peptides Derived from Granulysin1 , 2000, The Journal of Immunology.

[32]  T. Strom,et al.  Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. , 1998, Transplantation.

[33]  T. Strom,et al.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[35]  R. Zinkernagel,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[36]  K. Lucas,et al.  Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. , 2002, Blood.

[37]  A. Krensky,et al.  Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. , 1998, Journal of immunology.

[38]  R. Zinkernagel,et al.  CD8+ T cell‐mediated protection against an intracellular bacterium by perforin‐dependent cytotoxicity , 1994, European journal of immunology.

[39]  R. Herberman,et al.  Lymphocyte-mediated cytotoxicity. , 1987, Pediatric annals.

[40]  I. T. Ten Berge,et al.  Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. , 1998, Transplantation proceedings.

[41]  M. Bonneville,et al.  Granulysin-Dependent Killing of Intracellular and Extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T Lymphocytes , 2001 .